A 5th U.S. Circuit Court of Appeals panel blocked part of a Trump-appointed judge’s ruling that suspended the FDA’s approval of the abortion drug mifepristone.
A 5th U.S. Circuit Court of Appeals panel blocked part of a Donald Trump-appointed judge’s extreme ruling that suspended the FDA’s 2000 approval of the commonly used abortion drug mifepristone. But the three-judge panel approved part of the Trump judge’s ruling against more recent FDA actions starting in 2016 that improved access to the drug by, among other things, allowing people to receive it by mail and allowing the drug to be dispensed through 10 weeks instead of seven. Further litigation, including potentially at the Supreme Court, could more fully determine the fate of the drug’s availability.
The 5th Circuit panel said it appeared the statute of limitations blocked anti-abortion plaintiffs — who brought the case to U.
